Evogene Ltd.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-20.8M | $-19.6M | $-17.2M |
| Depreciation & Amortization | — | — | — |
| Depreciation | — | — | — |
| Amortization | — | — | — |
| Stock-Based Compensation | — | — | — |
| Net Cash from Operating Activities | $-15.9M | $-11.7M | $-12.4M |
| Investing Activities | |||
| Capital Expenditures | $590.0K | $808.0K | $2.0M |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $15.2M | $4.0M | $17.4M |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $814.0K | $655.0K | $45.0K |
| Net Change in Cash | $199.0K | $-7.0M | $5.0M |
| Free Cash Flow | $-16.5M | $-12.5M | $-14.4M |